The confirmation of altered DNAme at the CTSZ-associated CpG we identified in heritable PAH patient-derived PAEC through our analysis of public methylation data demonstrates that our approach has the potential to identify both blood cell-specific and systemic changes using a non-invasive sampling method. The gene discussed is CTSZ; the disease is pulmonary arterial hypertension.